Genomic Health, Inc.
GHDX
GHDX was delisted on the 7th of November, 2019.
113 hedge funds and large institutions have $963M invested in Genomic Health, Inc. in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 6 closing their positions.
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
22% more call options, than puts
Call options by funds: $429K | Put options by funds: $351K
14% more capital invested
Capital invested by funds: $847M → $963M (+$116M)
11% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 37
6% more funds holding
Funds holding: 107 → 113 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$8.26M |
| 2 |
BG
BlackRock Group
London,
United Kingdom
|
+$4.97M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$4.88M |
| 4 |
Millennium Management
New York
|
+$4.39M |
| 5 |
JP Morgan Chase
New York
|
+$3.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$21.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.8M |
| 3 |
MRM
Michael R. Murphy
|
-$8.25M |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$1.17M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$573K |
GHDX Hedge Fund Activity: Q4 2014 in Review
113 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2014, worth a combined $963M — up 14% from $847M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GHDX positions and 6 closed out — a net gain of 6 holders — while 41 added to existing stakes and 37 trimmed.
The largest buyer was BlackRock Advisors, adding an estimated $8.26M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $21.2M.
- 113 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2014, up from 107 in Q3 2014.
- Funds reported $963M of Genomic Health, Inc. stock for Q4 2014, up 14% quarter-over-quarter.
- 12 funds opened new Genomic Health, Inc. positions in Q4 2014 and 6 closed out, a net change of +6 holders.
- The largest Genomic Health, Inc. buyer in Q4 2014 was BlackRock Advisors, an estimated $8.26M added.
- The largest Genomic Health, Inc. seller in Q4 2014 was TPG Group Holdings (SBS) Advisors, an estimated $21.2M sold.
Based on aggregated 13F filings for Q4 2014.